Dr Tom Abbott

Profile

ORCID ID: 0000-0002-8664-3001

Dr Abbott is a Senior Clinical Lecturer in Anaesthesia and Perioperative Medicine with the Critical Care and Perioperative Medicine Research Group within the Faculty of Medicine and Dentistry and a Consultant Anaesthetist at the Royal London Hospital, Barts Health NHS Trust.

Dr Abbott graduated first in his class from Oxford University Medical School in 2011, receiving distinction and three prizes awarded by the University. He undertook a Medical Research Council Clinical Research Training Fellowship and was awarded a PhD in clinical epidemiology by Queen Mary University of London in 2017. He completed his postgraduate clinical training in Anaesthesia and Perioperative Medicine in 2024 with the London School of Anaesthesia. He held a NIHR Clinical Lectureship between 2021 and 2024, and was awarded an NIHR Development and Skills Enhancement Fellowship in 2025.

Dr Abbott uses epidemiological methods to investigate the health and wellbeing of patients undergoing surgery, which includes interventions to improve postoperative survival and reduce perioperative complications. Dr Abbott is the Chief Investigator of the PROTECT platform trial and the RESURGENT epidemiological study, and the co-chief investigator of the SAPPHIRE study.

Research

Group members
www.qmul.ac.uk/ccpmg/  

Dr Abbott uses epidemiological methods to investigate the health and wellbeing of patients undergoing surgery, which includes interventions to improve postoperative survival and reduce perioperative complications. He has taken a leading role in several international multi-centre cohort studies and clinical trials, and is the chief investigator for several on-going studies. He leads the PROTECT platform trial with Professor Rupert Pearse.  His research interests include perioperative infection and antimicrobial prophylaxis, perioperative respiratory failure, postoperative pulmonary complications, myocardial injury, sub-clinical cardiac failure, cardiopulmonary exercise testing, autonomic dysfunction, and the impact of COVID-19 on surgery.

Publications

• Lloyd P, Fowler AJ, Wozniak A et al. (2025). Environmental impact of commonly used anaesthetic agents: systematic literature review with narrative synthesis.

  
  

  DOI: 10.1016/j.bjao.2024.100362

  
  

  QMRO:
• Ackland G . Preoperative activation of the renineangiotensin system and myocardial injury in noncardiac surgery: exploratory mechanistic analysis of the SPACE randomised controlled trial.

  
  

  DOI: 10.1016/j.bja.2024.10.040

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/103266
• Giannas E, Dias P, Janssen H et al. (2024). Clinical management of stopping or continuing perioperative angiotensin II converting enzyme inhibitors and/or angiotensin receptor blockers: a survey of clinical opinion.

  
  

  DOI: 10.1016/j.bjao.2024.100313

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/100920
• Campbell RAS, Thevathasan T, Wong DJN et al. (2024). Critical care unit bed availability and postoperative outcomes: a multinational cohort study.

  
  

  DOI: 10.1111/anae.16383

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/100922
• Watson S-L, Fowler AJ, Dias P et al. (2024). The lifetime risk of surgery in England: a nationwide observational cohort study.

  
  

  DOI: 10.1016/j.bja.2024.06.028

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/100284
• KA M, SR K, N C et al. (2024). Development and external validation of the ‘Global Surgical-Site Infection’ (GloSSI) predictive model in adult patients undergoing gastrointestinal surgery.

  
  

  DOI: 10.1093/bjs/znae129

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/100996
• del Arroyo AG, Patel A, Abbott TEF et al. (2024). Preoperative N-terminal pro-B-type natriuretic peptide and myocardial injury after stopping or continuing renin–angiotensin system inhibitors in noncardiac surgery: a prespecified analysis of a phase 2 randomised controlled multicentre trial.

  
  

  DOI: 10.1016/j.bja.2024.01.010

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/96344
• Toader A-M, Campbell MK, Quint JK et al. . Using healthcare systems data for outcomes in clinical trials: issues to consider at the design stage.

  
  

  DOI: 10.1186/s13063-024-07926-z

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/94438
• Prowle JR, Croal B, Abbott TEF et al. (2024). Cystatin C or creatinine for pre-operative assessment of kidney function and risk of post-operative acute kidney injury: a secondary analysis of the METS cohort study.

  
  

  DOI: 10.1093/ckj/sfae004

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/94510
• Booth J, Fowler AJ, Pearse R et al. (2024). Dental Surgical Activity in Hospitals during COVID-19: A Nationwide Observational Cohort Study.

  
  

  DOI: 10.1177/23800844231216356

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/93702

Collaborators

Internal

• Prof. Rupert Pearse
• Prof Gareth Ackland
• Dr John Prowle
• Dr Yize Wan
• Dr Tim Stephens

External

• Dr Louise Savic (University of Leeds)
• Dr Tom Dobbs (University of Swansea)
• Prof R. Lyons (University of Swansea)
• Prof Duminda Wijeysundera (University of Toronto)
• Dr Joyce Yeung (University of Warwick)